Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Garenoxacin (BMS284756) is a novel oral des-fluoro(6) quinolone for the treatment of Gram-positive and Gram-negative bacterial infections.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約 35 days | ¥ 63,500 |
10 mg | 約 35 days | ¥ 95,000 |
25 mg | 約 35 days | ¥ 202,000 |
説明 | Garenoxacin (BMS284756) is a novel oral des-fluoro(6) quinolone for the treatment of Gram-positive and Gram-negative bacterial infections. |
別名 | BMS284756 |
分子量 | 426.41 |
分子式 | C23H20F2N2O4 |
CAS No. | 194804-75-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2 mg/mL (4.69 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Garenoxacin 194804-75-6 Microbiology/Virology Antibacterial S. pneumonia Swiss mice Inhibitor Antibiotic BMS 284756 BMS-284756 BMS284756 DNA/RNA Synthesis Topoisomerase S. aureus gyrase mycoplasmas topoisomerase IV ureaplasmas inhibit Bacterial inhibitor